Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of iron isomaltoside-1000 (Monofer((R)) ) versus ferric carboxy-maltose (Ferinject) in iron deficient anemia

Trial Profile

Study of iron isomaltoside-1000 (Monofer((R)) ) versus ferric carboxy-maltose (Ferinject) in iron deficient anemia

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2018

At a glance

  • Drugs Iron isomaltoside 1000 (Primary) ; Ferric carboxymaltose
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Nov 2018 New trial record
    • 04 Nov 2018 Results published in the British Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top